Injective INJ
Current Price
$3.25 +1.03%
$0.1700 Daily Range (5.23%)
$3.17$3.34
$50.31M Daily Volume
676 BTC
Vol/MktCap: 15.52%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $50.31M over the past 24 hours, compared to $57.75B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.28 -1.03%
13 SMA $3.28 -0.87%
21 SMA $3.25 +0.14%
55 SMA $3.15 +3.14%
144 SMA $3.08 +5.50%
Price Performance
+0.79% 1 Hour Change
$3.25 from $3.22
+9.82% 7 Day Change
$0.3192 from $2.93
+6.08% 14 Day Change
$0.1977 from $3.05
-0.79% 30 Day Change
-$0.0257 from $3.28
All Time High
March 14, 2024
$52.62 -93.84%
-$49.38 vs. now
24H Change
2.10M USD +0.65%
28 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
15.46M INJ
traded over past 24 hours
15.46% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.25, reflecting a 3.16% increase over the last 24 hours. The daily trading range is narrow, with a high of $3.34 and a low of $3.14, indicating relatively stable price action.
The trading volume of approximately $49.73 million suggests a healthy market interest, with a volume-to-market cap ratio of 15.31%. This level of volume supports the recent price movement and indicates that the market is engaged in trading activity.
Technical indicators show mixed signals, with the 8-hour Simple Moving Average (SMA) at $3.28 reflecting a slight decline of 0.87%. However, longer-term SMAs show a positive trend, with the 55 SMA at $3.12 and the 144 SMA at $3.07 both indicating upward momentum, up 4.03% and 5.99%, respectively.
The 1-hour Relative Strength Index (RSI) sits at 62, suggesting that INJ is approaching overbought territory, while the 7-day RSI at 58 indicates it is still in a neutral range. This divergence suggests that while short-term momentum may be fading, the medium-term trend remains healthy.
Over the past week, INJ has gained over 10%, indicating strong bullish sentiment, despite a minor decline over the last 30 days. The all-time high of $52.62 set in March 2024 highlights significant potential for future growth, although the current price is substantially lower, reflecting market volatility.
In conclusion, the combination of strong short-term gains, healthy trading volume, and supportive long-term moving averages indicates a bullish trend for Injective. Therefore, the rating for INJ is a Buy, as the current market dynamics and technical indicators suggest further upside potential.
The trading volume of approximately $49.73 million suggests a healthy market interest, with a volume-to-market cap ratio of 15.31%. This level of volume supports the recent price movement and indicates that the market is engaged in trading activity.
Technical indicators show mixed signals, with the 8-hour Simple Moving Average (SMA) at $3.28 reflecting a slight decline of 0.87%. However, longer-term SMAs show a positive trend, with the 55 SMA at $3.12 and the 144 SMA at $3.07 both indicating upward momentum, up 4.03% and 5.99%, respectively.
The 1-hour Relative Strength Index (RSI) sits at 62, suggesting that INJ is approaching overbought territory, while the 7-day RSI at 58 indicates it is still in a neutral range. This divergence suggests that while short-term momentum may be fading, the medium-term trend remains healthy.
Over the past week, INJ has gained over 10%, indicating strong bullish sentiment, despite a minor decline over the last 30 days. The all-time high of $52.62 set in March 2024 highlights significant potential for future growth, although the current price is substantially lower, reflecting market volatility.
In conclusion, the combination of strong short-term gains, healthy trading volume, and supportive long-term moving averages indicates a bullish trend for Injective. Therefore, the rating for INJ is a Buy, as the current market dynamics and technical indicators suggest further upside potential.
Updated 257 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like
In The News

SEC considers ending mandatory quarterly earnings reports for US companies: WSJ
SEC prepares proposal to make quarterly earnings reports optional, allowing U.S.

Central Bank of Russia Proposes Opening National Economy to International Markets Using Digital Assets
The institution has asked the government to allow digital financial assets to be issued on open networks like Ethereum, opening national businesses to international investments.

Playnance Launches GCOIN Staking As Community Locks Over 250 Million Tokens Within Hours
Tel Aviv, Israel, 16th March 2026,…

Ethereum Futures Volume Outruns Spot 6-to-1 As Macro Stress Weighs On Crypto
Ethereum has reclaimed the $2,200 level as the broader cryptocurrency market shows signs of short-term strength following several weeks of volatility and uncertain momentum.